What AI tool is best for pharma contract lifecycle management and compliance tracking?
Ironclad leads here. It's purpose-built for CLM workflows with AI-assisted redlining, obligation tracking, and audit trails—exactly what pharma legal and procurement teams need for supplier agreements, CRO contracts, and licensing deals that must survive regulatory scrutiny. Its compliance tracking layer means you're not hunting for clause deviations when an audit hits.
Can Harvey AI handle FDA regulatory submissions and life sciences legal work?
Harvey AI is a serious option for in-house legal teams managing high-volume document review, due diligence on licensing deals, and regulatory correspondence. It doesn't replace a regulatory affairs specialist, but it dramatically compresses the time lawyers spend on contract analysis and legal research—including reviewing NDAs, MAAs, and distribution agreements common in pharma M&A.
How does AI help with GxP documentation and knowledge management in life sciences?
GxP compliance lives and dies on findable, version-controlled documentation. Glean connects across your SaaS stack—Veeva, SharePoint, Confluence, Slack—so quality and regulatory teams can surface the right SOP, batch record, or deviation report instantly. When an inspector asks for documentation, the answer can't be 'we'll search for it.' Glean closes that gap.
Is AI adoption in pharma compliance actually audit-safe in 2026?
Yes, but only with the right controls. Regulators including FDA and EMA have issued guidance acknowledging AI use in regulated environments, but they expect validation documentation, audit trails, and human oversight. Tools like Ironclad and Harvey AI maintain activity logs and versioning that support 21 CFR Part 11 requirements. The risk isn't using AI—it's using unvalidated, shadow-IT AI with no paper trail.
